Australia TGA ARTG recordNeedle, subcutaneous injection/infusion port
Australia TGA ARTG Registered Device · Multigate Medical Devices Pty Ltd · Promisemed Hangzhou Meditech Co Ltd · Class IIa · Started July 27, 2022
Good Name: Multigate Medical Devices Pty Ltd - Needle, subcutaneous injection/infusion port
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- July 27, 2022
- Effective Date
- July 27, 2022
- Country
- China
- Address
- No 1388 Cangxing Street Cangqian Community Yuhang District, Hangzhou City, Zhejiang, 311121
It is intended for subcutaneous injection of insulin in the treatment of diabetes.
Access comprehensive regulatory information for Needle, subcutaneous injection/infusion port in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Multigate Medical Devices Pty Ltd, manufactured by Promisemed Hangzhou Meditech Co Ltd in China. The device registration started on July 27, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.